• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Axsome Thera (NQ: AXSM )

    88.84 -0.19 (-0.21%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Axsome Thera

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    19 20 Next >
    5 Top Stocks for July
    This basket of stocks has it all, including growth, dividend income, and value. 
    Via The Motley Fool
    Axsome Therapeutics Announces Closing of Public Offering of $225 Million of Shares of Common Stock
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    Why Shares of Axsome Therapeutics Fell Wednesday
    The biopharmaceutical company announced a $225 million stock sale. 
    Via The Motley Fool
    Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
    Via Benzinga
    2 Under-the-Radar Biotech Stocks to Buy in 2023
    These companies are coming into their own. 
    Via The Motley Fool
    Why Is Xponential Fitness (XPOF) Stock Up 19% Today?
    Xponential Fitness (XPOF) stock is climbing higher on Wednesday as the company strikes back against a short report from Fuzzy Panda Research. 
    Via InvestorPlace
    Why Is Axsome Therapeutics (AXSM) Stock Down 10% Today?
    Axsome Therapeutics (AXSM) stock is heading lower on Wednesday as investors react to the company pricing a public share offering. 
    Via InvestorPlace
    Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock
    Markets could have a tough time building on gains from Tuesday. 
    Via The Motley Fool
    Where Will Axsome Therapeutics Be in 3 Years?
    The stock soared more than 100% last year. 
    Via The Motley Fool
    This Stock Crushed the Market Last Year. Here's Why It Could Do That Again.
    This small biotech could become much bigger in just a few years. 
    Via The Motley Fool
    Is Axsome Therapeutics Stock a Screaming Buy?
    The biotech could be staring down an enormous commercial opportunity. 
    Via The Motley Fool
    Axsome Therapeutics Stock Is Moving Lower: What's Going On?
    Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading lower Wednesday after the company proposed a public offering of common stock. 
    Via Benzinga
    The Best Stocks to Invest $20,000 in Right Now
    You can invest in these companies with $20,000 -- or even a lot less. 
    Via The Motley Fool
    Axsome Therapeutics Announces Proposed Public Offering of Common Stock
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    2 Low-Priced Stocks That Could Make You Richer
    These two low-priced healthcare stocks could skyrocket within the next 12 months. 
    Via The Motley Fool
    3 Monster Stocks in the Making to Buy Right Now
    They're not monsters now -- but just give them some time. 
    Via The Motley Fool
    Why Axsome Therapeutics Stock Is Rising Today
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares are trading higher Wednesday following a recent corporate presentation. 
    Via Benzinga
    Analyst Expectations for Axsome Therapeutics's Future
    Via Benzinga
    3 Biotech Stocks to Buy as Companies Ink Major Deals
    Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy. 
    Via InvestorPlace
    Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now?
    Soaring sales of a new depression treatment could be just the tip of the iceberg for Axsome Therapeutics. 
    Via The Motley Fool
    Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review
    Stocks kept powering higher despite, but the Nasdaq is looking extended. 
    Via Investor's Business Daily
    Axsome Therapeutics Expects Up To $11.5 Billion In Peak Sales, Wallops Analysts' Forecasts
    The company's biggest products treats depression and could be used in other conditions. 
    Via Investor's Business Daily
    3 No-Brainer Stocks to Buy in June
    These biopharma stocks could be big winners. 
    Via The Motley Fool
    The Top Healthcare Stocks to Buy With $100
    You don't need a fortune to start investing. 
    Via The Motley Fool
    Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023
    Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apnea 
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    Prediction: These 2 Stocks Could Double In the Next Year
    It would be a continuation of solid recent performances. 
    Via The Motley Fool
    2 Biotech Stocks That Could Help Set You Up for Life
    These two promising companies have the potential to beat the market over time. 
    Via The Motley Fool
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    19 20 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.